Andrea is a seasoned healthcare executive with a unique blend of clinical and commercial expertise, specializing in oncology and cell therapy. With over 15 years of experience spanning clinical practice, medical affairs, and strategic leadership, she has played a pivotal role in the successful launch of transformative therapies, including Yescarta and Tecartus. Andrea holds an Oncology Nurse Practitioner degree and an MBA from Notre Dame, enabling her to bridge the gap between science and strategy.More...